» Articles » PMID: 33463194

Chitosan Microbeads Produced by One-Step Scalable Stirred Emulsification: A Promising Process for Cell Therapy Applications

Overview
Date 2021 Jan 19
PMID 33463194
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cell microencapsulation is a promising approach to improve cell therapy outcomes by protecting injected cells from rapid dispersion and allowing bidirectional diffusion of nutrients, oxygen, and waste that promote cell survival in the target tissues. Here, we describe a simple and scalable emulsification method to encapsulate animal cells in chitosan microbeads using thermosensitive gel formulations without any chemical modification and cross-linker. The process consists of a water-in-oil emulsion where the aqueous phase droplets contain cells (L929 fibroblasts or human mesenchymal stromal cells), chitosan acidic solution and gelling agents (sodium hydrogen carbonate and phosphate buffer or beta-glycerophosphate). The oil temperature is maintained at 37 °C, allowing rapid physical gelation of the microbeads. Alginate beads prepared with the same method were used as a control. Microbeads with a diameter of 300-450 μm were successfully produced. Chitosan and alginate (2% w/v) microbeads presented similar rigidity in compression, but chitosan microbeads endured >80% strain without rupture, while alginate microbeads presented fragile breakage at <50% strain. High cell viability and metabolic activity were observed after up to 7 days in culture for encapsulated cells. Mesenchymal stromal cells encapsulated in chitosan microbeads released higher amounts of the vascular endothelial growth factor after 24 h compared to the cells encapsulated in manually cast macrogels. Moreover, microbeads were injectable through 23G needles without significant deformation or rupture. The emulsion-generated chitosan microbeads are a promising delivery vehicle for therapeutic cells because of their cytocompatibility, biodegradation, mechanical strength, and injectability. Clinical-scale encapsulation of therapeutic cells such as mesenchymal stromal cells in chitosan microbeads can readily be achieved using this simple and scalable emulsion-based process.

Citing Articles

Stimuli-Responsive Self-Healing Ionic Gels: A Promising Approach for Dermal and Tissue Engineering Applications.

Datta D, Colaco V, Bandi S, Dhas N, Janardhanam L, Singh S ACS Biomater Sci Eng. 2025; 11(3):1338-1372.

PMID: 39999055 PMC: 11897956. DOI: 10.1021/acsbiomaterials.4c02264.


In Vivo Mouse Abdominal Oxygen Imaging And Assessment of Subcutaneously Implanted Beta Cell Replacement Devices.

Canavesi I, Viswakarma N, Epel B, Kotecha M Mol Imaging Biol. 2024; 27(1):64-77.

PMID: 39633071 DOI: 10.1007/s11307-024-01963-5.


In vitro oxygen imaging of acellular and cell-loaded beta cell replacement devices.

Kotecha M, Wang L, Hameed S, Viswakarma N, Ma M, Stabler C Sci Rep. 2023; 13(1):15641.

PMID: 37730815 PMC: 10511476. DOI: 10.1038/s41598-023-42099-w.


Emerging Trends in Biodegradable Microcarriers for Therapeutic Applications.

Handral H, Wyrobnik T, Lam A Polymers (Basel). 2023; 15(6).

PMID: 36987266 PMC: 10057597. DOI: 10.3390/polym15061487.


Biomaterials for enhanced immunotherapy.

Cunningham N, Lapointe R, Lerouge S APL Bioeng. 2022; 6(4):041502.

PMID: 36561511 PMC: 9767681. DOI: 10.1063/5.0125692.